nimodipine has been researched along with Cerebral Arterial Diseases in 7 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Cerebral Arterial Diseases: Pathological conditions of intracranial ARTERIES supplying the CEREBRUM. These diseases often are due to abnormalities or pathological processes in the ANTERIOR CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY; and POSTERIOR CEREBRAL ARTERY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To prevent and treat the ischemic complications due to the vasospasm, this report suggest the management of aneurysmal subarachnoid haemorrhage by the association of antifibrinolytics (tranexamic acid) to lower the risk of rebleeding, calcium channel blockers (nimodipine), and the keeping of an effective total blood volume (thanks to volume expansion and dopamine)." | 3.68 | [Evaluation of the treatment of aneurysmal meningeal hemorrhage with antifibrinolytic agents, calcium inhibitors and maintenance of effective blood volume]. ( Berard, JP; Cavaroc, G; Greil, P; Gutknecht, JL; Halberstadt, J; Irthum, B; Planchon, E, 1990) |
| "A consecutive series of 100 individuals with aneurysmal subarachnoid hemorrhage were subjected to early aneurysm operation followed by subsequent intravenous administration of the calcium antagonist nimodipine during the critical period for symptomatic vasospasm." | 3.67 | Delayed ischemic deterioration in patients with early aneurysm operation and intravenous nimodipine. ( Brandt, L; Ljunggren, B; Messeter, K; Säveland, H, 1986) |
| "Pediatric stroke is considered an infrequent complication of COVID-19." | 1.72 | Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine. ( Aharoni, S; Auriel, E; Avital, D; Bulkowstein, Y; Inbar, E; Konen, O; Nahum, E; Nevo, Y; Peretz, S; Perlow, E; Straussberg, R; Vig, LC, 2022) |
| "These two syndromes have similar symptoms but may have different treatments, thus highlighting the importance of a correct diagnosis." | 1.51 | Posterior reversible encephalopathy syndrome associated with reversible cerebral vasoconstriction syndrome in a patient presenting with postpartum eclampsia: A case report. ( Auliac, SC; Ayoubi, JM; Carbonnel, M; Josserand, J; Pop, A; Wang, A, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Avital, D | 1 |
| Peretz, S | 1 |
| Perlow, E | 1 |
| Konen, O | 1 |
| Inbar, E | 1 |
| Bulkowstein, Y | 1 |
| Nahum, E | 1 |
| Aharoni, S | 1 |
| Vig, LC | 1 |
| Nevo, Y | 1 |
| Auriel, E | 1 |
| Straussberg, R | 1 |
| Pop, A | 1 |
| Carbonnel, M | 1 |
| Wang, A | 1 |
| Josserand, J | 1 |
| Auliac, SC | 1 |
| Ayoubi, JM | 1 |
| Gutknecht, JL | 1 |
| Irthum, B | 1 |
| Cavaroc, G | 1 |
| Halberstadt, J | 1 |
| Planchon, E | 1 |
| Greil, P | 1 |
| Berard, JP | 1 |
| Jaboulay, JM | 1 |
| Chacornac, R | 1 |
| Riche, H | 1 |
| Salord, F | 1 |
| Philippon, B | 1 |
| Adnet, P | 1 |
| Moinardeau, V | 1 |
| Riegel, B | 1 |
| Lejeune, JP | 1 |
| Fesard, F | 1 |
| Debout, J | 1 |
| Krivosic-Horber, R | 1 |
| Allen, GS | 1 |
| Säveland, H | 1 |
| Ljunggren, B | 1 |
| Brandt, L | 1 |
| Messeter, K | 1 |
2 reviews available for nimodipine and Cerebral Arterial Diseases
| Article | Year |
|---|---|
[Intravascular volume expansion and intravenous nimodipine in the treatment of cerebral vasospasm after surgical treatment of intracranial aneurysm].
Topics: Adult; Cerebral Arterial Diseases; Dopamine; Fluid Therapy; Hemodynamics; Humans; Infusions, Intrave | 1990 |
Cerebral arterial spasm.
Topics: Blood Platelets; Calcium; Cerebral Arterial Diseases; Humans; Muscle Contraction; Nervous System Dis | 1985 |
5 other studies available for nimodipine and Cerebral Arterial Diseases
| Article | Year |
|---|---|
Clinical improvement of a toddler with COVID-19 focal cerebral arteriopathy possibly due to intra-arterial nimodipine.
Topics: Cerebral Arterial Diseases; Child; Child, Preschool; COVID-19; Humans; Nimodipine; SARS-CoV-2; Strok | 2022 |
Posterior reversible encephalopathy syndrome associated with reversible cerebral vasoconstriction syndrome in a patient presenting with postpartum eclampsia: A case report.
Topics: Adult; Cerebral Arterial Diseases; Eclampsia; Female; Headache; Humans; Nimodipine; Posterior Leukoe | 2019 |
[Evaluation of the treatment of aneurysmal meningeal hemorrhage with antifibrinolytic agents, calcium inhibitors and maintenance of effective blood volume].
Topics: Adolescent; Adult; Aged; Cerebral Arterial Diseases; Child; Child, Preschool; Clinical Protocols; Fe | 1990 |
[Value of cerebral blood flow study with nimodipine test in intracranial aneurysm].
Topics: Adolescent; Adult; Aged; Brain Ischemia; Cerebral Arterial Diseases; Cerebrovascular Circulation; Fe | 1990 |
Delayed ischemic deterioration in patients with early aneurysm operation and intravenous nimodipine.
Topics: Brain Ischemia; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Arterial Diseases; Combi | 1986 |